Cargando…
Antibody-based therapies for COVID-19: Can Europe move faster?
Michel Goldman and colleagues call on the European medical and scientific community to coordinate efforts on immunotherapy-based approaches to coronavirus.
Autores principales: | Kazatchkine, Michel D., Goldman, Michel, Vincent, Jean-Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200003/ https://www.ncbi.nlm.nih.gov/pubmed/32369479 http://dx.doi.org/10.1371/journal.pmed.1003127 |
Ejemplares similares
-
Drug use, HIV, HCV and TB: major interlinked challenges in Eastern Europe and Central Asia
por: Kazatchkine, Michel
Publicado: (2014) -
The expanding epidemic of HIV-1 in the Russian Federation
por: Beyrer, Chris, et al.
Publicado: (2017) -
Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity
por: Goldman, Michel, et al.
Publicado: (2021) -
No time for complacency on COVID-19 in Europe
por: Flahault, Antoine, et al.
Publicado: (2023) -
COVID-19 in India: Moving from containment to mitigation
por: Varghese, George M., et al.
Publicado: (2020)